Disease-related mutations among caribbean hispanics with familial dementia

Molecular Genetics and Genomic Medicine

Volumn 2, Issue 5, 2014, Pages 430-437

  Lee, Joseph H ^a,b   Kahn, Amanda ^a   Cheng, Rong ^a,b   Reitz, Christiane ^a,b   Vardarajan, Badri ^a,b   Lantigua, Rafael ^a,c   Medrano, Martin ^d   Jiméenez Veléazquez, Ivonne Z ^e   Williamson, Jennifer ^a,b   Nagy, Peter ^a   Mayeux, Richard ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c University of Puerto Rico School of Medicine ^*  (United States)

^d Pontificia Universidad Catolica Madre y Maestra   (Dominican Republic)

^e UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Alzheimer s disease; Caribbean Hispanics; Familial dementia; Mutations; Next generation sequencing

Indexed keywords

EID: 84927590524     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.85     Document Type: Article

References (30)

1. Arango, D., M. Cruts, O. Torres, H. Backhovens, M. L. Serrano, E. Villareal, et al. 2001. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. Am. J. Med. Genet. 103:138–143.
2. Athan, E. S., J. Williamson, A. Ciappa, V. Santana, S. N. Romas, J. H. Lee, et al. 2001. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA 286:2257– 2263.
3. Berezovska, O., A. Lleo, L. D. Herl, M. P. Frosch, E. A. Stern, B. J. Bacskai, et al. 2005. Familial Alzheimer’s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J. Neurosci. 25:3009–3017.
4. Bertoli Avella, A. M., B. Marcheco Teruel, J. J. Llibre Rodriguez, N. Gomez Viera, I. Borrajero Martinez, E. A. Severijnen, et al. 2002. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease. Neurogenetics 4:97–104.
5. van Broeckhoven, C. 1995. Presenilins and Alzheimer disease. Nat. Genet. 11:230–232.
6. van Broeckhoven, C., H. Backhovens, M. Cruts, G. de Winter, M. Bruyland, P. Cras, et al. 1992. Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3. Nat. Genet. 2:335–339.
7. Cruchaga, C., G. Haller, S. Chakraverty, K. Mayo, F. L. Vallania, R. D. Mitra, et al. 2012. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families. PLoS One 7:e31039.
8. Cruts, M., and C. van Broeckhoven. 1998a. Molecular genetics of Alzheimer’s disease. Ann. Med. 30:560–565.
9. Cruts, M., and C. van Broeckhoven. 1998b. Presenilin mutations in Alzheimer’s disease. Hum. Mutat. 11:183–190.
10. Cruts, M., J. Theuns, and C. van Broeckhoven. 2012. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 33:1340–1344.
11. Doran, M., D. G. du Plessis, E. J. Ghadiali, D. M. Mann, S. Pickering-Brown, and A. J. Larner. 2007. Familial early-onset dementia with tau intron 10 + 16 mutation with clinical features similar to those of Alzheimer disease. Arch. Neurol. 64:1535–1539.
12. Fenoglio, C., D. Galimberti, F. Cortini, J. S. Kauwe, C. Cruchaga, E. Venturelli, et al. 2009. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. J. Alzheimers Dis. 18:603–612.
13. Gijselinck, I., C. van Broeckhoven, and M. Cruts. 2008. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum. Mutat. 29:1373–1386.
14. Goring, H. H. H., and J. D. Terwilliger. 2000. Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. Am. J. Hum. Genet. 66:1310–1327.
15. Helisalmi, S., M. Hiltunen, A. Mannermaa, A. M. Koivisto, M. Lehtovirta, I. Alafuzoff, et al. 2000. Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer’s disease? Neurosci. Lett. 278:65–68.
16. Hiekkalinna, T., A. A. Schaffer, B. Lambert, P. Norrgrann, H. H. H. Goring, and J. D. Terwilliger. 2011. PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum. Hered. 71:256–266.
17. Jin, S. C., P. Pastor, B. Cooper, S. Cervantes, B. A. Benitez, C. Razquin, C. Cruchaga. 2012. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer’s disease Ibero-American cohort. Alzheimers Res. Ther. 4:34.
18. Kumar, P., S. Henikoff, and P. C. Ng. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4:1073– 1081.
19. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944.
20. Morelli, L., M. I. Prat, E. Levy, C. A. Mangone, and E. M. Castano. 1998. Presenilin 1 Met146Leu variant due to an A –> T transversion in an early-onset familial Alzheimer’s disease pedigree from Argentina. Clin. Genet. 53:469–473.
21. Ng, P. C., and S. Henikoff. 2001. Predicting deleterious amino acid substitutions. Genome Res. 11:863–874.
22. Rademakers, R., M. Cruts, and C. van Broeckhoven. 2003a. Genetics of early-onset Alzheimer dementia. Sci. World J. 3:497–519.
23. Rademakers, R., B. Dermaut, K. Peeters, M. Cruts, P. Heutink, A. Goate, et al. 2003b. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum. Mutat. 22:409– 411.
24. Ramirez-Duenas, M. G., E. A. Rogaeva, C. A. Leal, C. Lin, G. A. Ramirez-Casillas, J. A. Hernandez-Romo, et al. 1998. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset Alzheimer disease. Ann. Genet. 41:149–153.
25. Rogaeva, E. A., K. C. Fafel, Y. Q. Song, H. Medeiros, C. Sato, Y. Liang, et al. 2001. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 57:621–625.
26. Sherrington, R., E. I. Rogaev, Y. Liang, E. A. Rogaeva, G. Levesque, M. Ikeda, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375:754–760.
27. St George-Hyslop, P. H., and A. Petit. 2005. Molecular biology and genetics of Alzheimer’s disease. C R Biol. 328:119–130.
28. Tanzi, R. E., and L. Bertram. 2001. New frontiers in Alzheimer’s disease genetics. Neuron 32:181–184.
29. Wijsman, E. M., N. D. Pankratz, Y. Choi, J. H. Rothstein, K. M. Faber, R. Cheng, et al. 2011. Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 7:e1001308.
30. Wojtas, A., K. A. Heggeli, N. Finch, M. Baker, M. Dejesus-Hernandez, S. G. Younkin, et al. 2012. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am. J. Neurodegener. Dis. 1:107–118.